Variability in the assessment of adverse events in a multicenter clinical trial

Clinical Therapeutics

Volumn 23, Issue 12, 2001, Pages 2011-2020

  Raisch, Dennis W ^a,b,d   Troutman, William G ^b   Sather, Mike R ^a,b   Fudala, Paul J ^c  

^a University of New Mexico   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Adverse events; Clinical investigations; Research

Indexed keywords

NEW DRUG;

ACCURACY; ARTICLE; CHI SQUARE TEST; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; EVALUATION; FLUSHING; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; MULTICENTER STUDY; OBSERVER VARIATION; OPIATE ADDICTION; PERSONNEL; PHARMACIST; RELIABILITY; VOMITING;

EID: 0035690304     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80153-3     Document Type: Article

References (19)

1. Evaluation of safety data from controlled clinical trials: The clinical principles explained
2. Adverse drug reactions: Comparison of two report methods
3. Under-reporting of adverse drug reactions in the elderly
4. Spontaneous reporting of adverse drug reactions: Who reports and what?
5. Causality assessment of suspected adverse drug reactions: A transatlantic view
6. Role and place of causality assessment
7. Geographical variation in adverse event reporting rates in clinical trials
8. Reliability and validity of judgments concerning adverse events suffered by hospitalized patients
9. Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial
10. A method for estimating the probability of adverse drug reactions
11. The case of one sample, two measures or paired replicates
12. Correction for multiple comparisons
13. Bias and confounding factors
14. Specific factors to consider in interpreting efficacy and safety data
15. Assessing methods for causality assessment of suspected adverse drug reactions
16. Influence of clinical knowledge, organizational context, and practice style on transfusion decision making. Implications for practice change strategies
17. Physicians' judgments of the risks of cardiac procedures. Differences between cardiologists and other internists
18. A clinical decision support system for prevention of venous thromboembolism: Effect on physician behavior
19. Interpretation of adverse reactions